Daniel Matlis, President of Axendia and Jordan Reynolds, Senior Manager, Kalypso, will discuss how innovative companies should navigate the perilous intersection of FDA approval, quality manufacturing and support for superior patient outcomes during a live webinar at 1:30pm Eastern on June 20, 2017.
The device industry is changing rapidly — and with change you have winners and losers. Today’s winners are embracing connectivity and the quickly emerging internet of medical things (IoMT) movement. They understand that the future is continuous glucose monitoring systems that connect to handheld meters, sensor-embedded hospital beds that proactively alert providers to problems, wearable mHealth devices which can send information to caregivers or a multitude of other remote patient monitoring technologies.
Getting these new products approved by the FDA is hard enough, making sure they connect properly with patients, physicians and healthcare centers is even harder.
Register today to learn how smart, connected devices are changing the device ecosystem in support of patient outcomes.